Education
About Us
Working with TipRanks
Follow Us
InMed Pharmaceuticals (INM)
NASDAQ:INM
InMed Pharmaceuticals (INM) Ownership Overview
13.79%
Insiders
10.22% Other Institutional Investors
75.99% Public Companies and
Individual Investors
The ownership structure of InMed Pharmaceuticals (INM) stock is a mix of institutional, retail, and individual investors. , 13.79% is owned by Insiders, and 75.99% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 304,595 | Insider | 10.86% | 519,334 | |
| 28,460 | Institution | 2.36% | 89,934 | |
| 43,959 | Insider | 1.57% | 74,950 | |
| 38,258 | Insider | 1.36% | 65,230 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns InMed Pharmaceuticals (INM)?
According to the latest TipRanks data, approximately 10.22% of the company's stock is held by institutional investors, 13.79% is held by insiders, and 75.99% is held by retail investors.
What percentage of InMed Pharmaceuticals (INM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 10.22% of InMed Pharmaceuticals (INM) stock is held by institutional investors.
What percentage of InMed Pharmaceuticals (INM) stock is held by retail investors?
According to the latest TipRanks data, approximately 75.99% of InMed Pharmaceuticals (INM) stock is held by retail investors.
Who owns the most shares of InMed Pharmaceuticals (INM)?
Shane Aaron Johnson owns the most shares of InMed Pharmaceuticals (INM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.